Rhythm Pharmaceuticals, Inc. RYTM
86.44 USD -7.00 (-7.49%)
At closeNov 3, 2026, 7:40 PM EST
88.42 +1.98 +2.29%
After hours · Nov 3, 7:40 PM ET
81.58 Day range 89.28
74.50 52-week range 122.20
- YTD
- -19.25%
- 1 year
- -24.00%
Analyst view
Consensus: strong buy
Strong buy
Price target (mean) 140.53 +62.6% upside
Now 86.44
- Target (low)
- 120.00
- Target (mean)
- 140.53
- Target (high)
- 160.00
Ratings (0m) 19 17 buy · 2 hold · 0 sell
- Strong buy5
- Buy12
- Hold2
- Sell0
- Strong sell0
Recommendation trend
- This month 19
- 1 month ago 18
- 2 months ago 17
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | -0.72859 | -0.93 – -0.57 | -0.73 | +0.2% | 99.51M | +73.8% | 13 |
| Next quarter | -0.71371 | -0.91484 – -0.45 | -0.83 | +14.0% | 104.17M | +73.3% | 4 |
| Current year | -3.04 | -3.36 – -2.82 | -3.11 | +2.1% | 315.25M | +66.1% | 13 |
| Next year | -0.6285 | -2.45 – 0.49 | -3.04 | +79.3% | 565.12M | +79.3% | 13 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Nov 3, 2026 | Needham | Maintained | Buy | Buy |
| Oct 16, 2026 | William Blair | Initiated | — | Outperform |
| Oct 15, 2026 | JP Morgan | Maintained | Overweight | Overweight |
| Oct 12, 2026 | HC Wainwright & Co. | Maintained | Buy | Buy |
| Oct 8, 2026 | RBC Capital | Maintained | Outperform | Outperform |
| Aug 28, 2026 | Deutsche Bank | Initiated | — | Hold |
| Aug 7, 2026 | JP Morgan | Maintained | Overweight | Overweight |
| Aug 5, 2026 | Citigroup | Maintained | Buy | Buy |
| Aug 5, 2026 | RBC Capital | Maintained | Outperform | Outperform |
| Aug 5, 2026 | Citizens | Maintained | Market Outperform | Market Outperform |
| Jul 27, 2026 | JP Morgan | Initiated | — | Overweight |
| Jul 7, 2026 | RBC Capital | Maintained | Outperform | Outperform |
| Jun 16, 2026 | Canaccord Genuity | Maintained | Buy | Buy |
| Jun 15, 2026 | Wells Fargo | Maintained | Overweight | Overweight |
| May 7, 2026 | Canaccord Genuity | Maintained | Buy | Buy |
| May 6, 2026 | RBC Capital | Maintained | Outperform | Outperform |
| May 6, 2026 | Wells Fargo | Maintained | Overweight | Overweight |
| Mar 23, 2026 | HC Wainwright & Co. | Maintained | Buy | Buy |
| Mar 20, 2026 | Citigroup | Maintained | Buy | Buy |
| Mar 20, 2026 | B of A Securities | Maintained | Buy | Buy |
| Mar 20, 2026 | Citizens | Maintained | Market Outperform | Market Outperform |
| Mar 18, 2026 | HC Wainwright & Co. | Maintained | Buy | Buy |
| Mar 17, 2026 | Citigroup | Maintained | Buy | Buy |
| Mar 17, 2026 | RBC Capital | Maintained | Outperform | Outperform |
| Mar 17, 2026 | Citizens | Maintained | Market Outperform | Market Outperform |
| Mar 17, 2026 | B of A Securities | Maintained | Buy | Buy |
| Mar 17, 2026 | Morgan Stanley | Maintained | Overweight | Overweight |
| Mar 17, 2026 | Needham | Maintained | Buy | Buy |
| Mar 12, 2026 | Wells Fargo | Maintained | Overweight | Overweight |
| Mar 2, 2026 | Canaccord Genuity | Maintained | Buy | Buy |